NEW YORK, March 20, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins.

jwplayer.key=”3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=”   Pre-Market update + Federal Reserve updates its forecast jwplayer(‘myplayer1’).setup({file: ‘https://mma.prnasia.com/media2/2646307/NYSE_March_20_Market_Update.mp4’, image: ‘https://mma.prnasia.com/media2/2646307/NYSE_March_20_Market_Update.mp4?p=thumbnail’, autostart:’false’, stretching : ‘uniform’, width: ‘512’, height: ‘288’});

Kristen Scholer delivers the pre-market update on March 20th

Stocks moved between gains and losses in the wake of the Federal Reserve’s interest rate decision and updated economic forecast yesterday. The Fed kept rates unchanged and lowered its GDP growth forecast for the year to 1.7 percent and upped its inflation projection to 2.8 percent. Fed Chair Jerome Powell noted that the central bank isn’t in a hurry to cut rates further while adding that an inflationary impact from tariffs is perceived as transitory for now.

Watch NYSE TV Live every weekday 9:00-10:00am ET 

 

Video – https://mma.prnasia.com/media2/2646307/NYSE_March_20_Market_Update.mp4

 

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Hyundai Motor Group Innovation Center Singapore Celebrates First Anniversary with Group Executive Chair Euisun Chung

Hyundai Motor Group celebrates a year of innovation at HMGICS, a key hub…

The World's First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia

CorrectSequence Therapeutics’ CS-121 Completed Dosing of First Chylomicronemia Patient, Demonstrating Excellent Safety…

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Colorectal Cancer of Biparatopic HER2-targeting ADC JSKN003

SUZHOU, China, Feb. 14, 2026 /PRNewswire/ — Alphamab Oncology (stock code: 9966.HK)…